of Clinical and Basic Cardiology

beta-blockers improve prognosis post myocardial infarction; benefit being demonstrated in many categories, particular value has been shown in patients with poor left ventricular function. The first non-predicted use of beta-blockers demonstrated was their antihypertensive effect. They are now accepted by major international guidelines as first line therapy. Beta 1 -selective agents are more effective than non-selective agents, and contrary to some earlier evidence based on non-selective agents, they are often effective in younger (under 65) black patients. Beta-blockers have been shown to improve prognosis in younger patients while in the elderly, diuretics appear superior in primary prevention. Since

[1]  Bisoprolol , 2020, Reactions Weekly.

[2]  A. Battler,et al.  Treatment of stable angina , 2007, Heart.

[3]  Jeroen J. Bax,et al.  The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery , 2000 .

[4]  W. Abraham Beta-blockers: the new standard of therapy for mild heart failure. , 2000, Archives of internal medicine.

[5]  J. Cruickshank Beta-blockers continue to surprise us. , 2000, European heart journal.

[6]  L. Poston,et al.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.

[7]  M. Fowler,et al.  Clinical Trials of Carvedilol in Heart Failure , 1999, Heart Failure Reviews.

[8]  J. Cleland,et al.  Carvedilol for Heart Failure: Clinical Trials in Progress , 1999, Heart Failure Reviews.

[9]  A. Fletcher,et al.  Quality of life in the management of hypertension. , 1999, Clinical and experimental hypertension.

[10]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[11]  K. Goa,et al.  Nebivolol in the Management of Essential Hypertension , 1999, Drugs.

[12]  P. Stone,et al.  Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. , 1999, The American journal of cardiology.

[13]  CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[14]  M. Weir The rationale for combination versus single-entity therapy in hypertension. , 1998, American journal of hypertension.

[15]  M. Packer,et al.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.

[16]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[17]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[18]  J. Parker Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials. , 1998, European heart journal.

[19]  W. Parmley Optimum Treatment of Stable Angina Pectoris , 1998, Cardiovascular Drugs and Therapy.

[20]  A. Hjalmarson,et al.  Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. , 1997, The American journal of cardiology.

[21]  S. Wellek,et al.  Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study , 1997, BMJ.

[22]  W. Ray,et al.  Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, JAMA.

[23]  S. Goldstein Beta-Blocking Drugs and Coronary Heart Disease , 1997, Cardiovascular Drugs and Therapy.

[24]  A. Stewart,et al.  Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. , 1997, Archives of internal medicine.

[25]  B. Psaty,et al.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.

[26]  P. Raskin,et al.  Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. , 1996, American journal of hypertension.

[27]  K. Jamerson,et al.  The impact of ethnicity on response to antihypertensive therapy. , 1996, The American journal of medicine.

[28]  G. Bakris,et al.  Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. , 1996, Archives of internal medicine.

[29]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[30]  C. Tack,et al.  Effects of Insulin on Vascular Tone and Sympathetic Nervous System in NIDDM , 1996, Diabetes.

[31]  M. Safar,et al.  Effects of antihypertensive drugs on large artery compliance. , 1995, The Netherlands journal of medicine.

[32]  V. Papademetriou,et al.  Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. , 1995, American heart journal.

[33]  B. Meier [Beta blockers in clinical practice]. , 1995, Praxis.

[34]  W. Frishman,et al.  First‐Line Therapy Option with Low‐Dose Bisoprolol Fumarate and Low‐Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic Hypertension , 1995, Journal of clinical pharmacology.

[35]  B. Strauer,et al.  Peripheral vascular effects of beta-blockers. , 1994, European heart journal.

[36]  K. Koury,et al.  A Multifactorial Trial Design to Assess Combination Therapy in Hypertension: Treatment With Bisoprolol and Hydrochlorothiazide , 1994 .

[37]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[38]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[39]  V. Papademetriou,et al.  Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. , 1993, The American journal of medicine.

[40]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[41]  A E Fletcher,et al.  Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. , 1992, Hypertension.

[42]  H. Black Metabolic considerations in the choice of therapy for the patient with hypertension. , 1991, American heart journal.

[43]  B. L. Wilson,et al.  Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. , 1990, Journal of human hypertension.

[44]  C. Bulpitt,et al.  Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. , 1990, Journal of hypertension.

[45]  J. Tuomilehto,et al.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.

[46]  J. Wikstrand BETA‐BLOCKERS AND CARDIOPROTECTION–IS THERE ANY GOOD NEWS FROM THE RECENT TRIALS? , 1987, Journal of clinical pharmacy and therapeutics.

[47]  J. Tuomilehto,et al.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.

[48]  E. Antman,et al.  Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. , 1987, The American journal of cardiology.

[49]  A. Zanchetti,et al.  Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[50]  A. Zanchetti,et al.  Double‐Blind Comparison of the Cardioselective &bgr;‐Blockers Bisoprolol and Atenolol in Hypertension: The Bisoprolol International Multicenter Study (BIMS) , 1985, Journal of cardiovascular pharmacology.

[51]  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. , 1985, British medical journal.

[52]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[53]  J. Kenny,et al.  Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris. , 1985, British heart journal.

[54]  A. Quyyumi,et al.  Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. , 1984, British medical journal.

[55]  M. Bassan,et al.  The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect. , 1983, Chest.

[56]  P. Tanser Management of stable angina pectoris. , 1977, Canadian family physician Medecin de famille canadien.

[57]  T. Pitkäjärvi,et al.  The use of clonidine and practolol in the treatment of hypertension. , 1976, Annals of clinical research.

[58]  P. Lockwood,et al.  [Use of propranolol in treatment of hypertension]. , 1972, Revue medicale de Liege.

[59]  P. Gillam,et al.  Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise. , 1971, British heart journal.

[60]  B. Prichard,et al.  Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. , 1966, The American journal of cardiology.

[61]  P. Snow Treatment of acute myocardial infarction with propranolol. , 1966, The American journal of cardiology.

[62]  P. Gillam,et al.  Use of Propranolol in Angina Pectoris , 1965, British medical journal.

[63]  J. A. Robinson Clinics , 1883, The Dental register.

[64]  U. Goldbourt,et al.  Are b-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly? , 2017 .

[65]  T. Hasegawa [Mild hypertension]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[66]  M. Bristow beta-adrenergic receptor blockade in chronic heart failure. , 2000, Circulation.

[67]  J. Staessen,et al.  Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension. , 1999, European heart journal.

[68]  M. Moser A critique of the world health organization-international society of hypertension guidelines for the management of hypertension , 1999 .

[69]  S. Julius,et al.  Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes. , 1998, Blood pressure. Supplement.

[70]  Detection The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[71]  B. Karlberg,et al.  Quality of life in hypertensive patients treated with either carvedilol or enalapril. , 1996, Blood pressure.

[72]  C. Dollery,et al.  Medical Research Council trial of treatment of hypertension in older adults: principal results. , 1992 .

[73]  K. Swedberg,et al.  Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study. , 1991, Journal of internal medicine. Supplement.

[74]  P. Saul,et al.  Comparison of β‐Blockade and ACE Inhibitors in the Treatment of Hypertension , 1990 .

[75]  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.

[76]  W. de Oliveira Júnior [The effects of antihypertensive therapy on the quality of life]. , 1989, Arquivos brasileiros de cardiologia.

[77]  D. Gau MILD HYPERTENSION: IS THERE PRESSURE TO TREAT? , 1988 .

[78]  E. Raftery,et al.  Combined therapy with verapamil and propranolol in chronic stable angina. , 1982, The American journal of cardiology.

[79]  P. Gillam,et al.  Discovery of the hypotensive effect of propranolol. , 1976, Postgraduate medical journal.